Protection against oxidative stress by vitamin D in cone cells

Cell Biochemistry and Function

Volumn 34, Issue 2, 2016, Pages 82-94

  Tohari, Ali Mohammad ^a,b   Zhou, Xinzhi ^a   Shu, Xinhua ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

Author keywords

Cone cells; Cytokines; Oxidative stress; Photoreceptor cell death; Retina; Vitamin D

Indexed keywords

ANTIOXIDANT; CALCITRIOL; COLECALCIFEROL; CYTOKINE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; VITAMIN D;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR CELL; PHOTORECEPTOR DEGENERATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RETINA CONE; RETINA DEGENERATION; ANIMAL; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MOUSE; STRUCTURE ACTIVITY RELATION; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINAL CONE PHOTORECEPTOR CELLS; STRUCTURE-ACTIVITY RELATIONSHIP; VITAMIN D;

EID: 84960260164     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3167     Document Type: Article

References (61)

1. Norman A. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88: 491S-499S.
2. Hossein-nezhad HM, Holick M. Vitamin D for health: a global perspective. Mayo Clin Proc 2013; 88: 720-755.
3. Lehmann B, Meurer M. Vitamin D metabolism. Dermatol Ther 2010; 23: 2-12.
4. 3 reduces inflammatory response in human periodontal ligament cells. PLoS One 2014; 9: 1-10.
5. 3 inhibits vascular cellular adhesion molecule-1 expression and interleukin-8 production in human coronary arterial endothelial cells. J Steroid Biochem Mol Biol 2012; 132: 290-294.
6. 3 inhibits pro-inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunol Cell Biol 2002; 80: 323-327.
7. 3 on cytokine production by human corneal epithelial cells. Curr Eye Res 2000; 20: 127-130.
8. 3: implications in cell growth and differentiation. Endocr Rev 2002; 23: 763-786.
9. Panichi V, De Pietro S, Andreini B, et al. Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Kidney Int 1998; 54: 1463-1469.
10. O'Kelly J, Junichi H, Yasako H, Bishop J, Norman A, Koeffler HP. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest 2002; 109: 1091-1099.
11. 3 in primary keratinocytes. J Immunol 2006; 15: 3780-3787.
12. 3 in breast epithelial cells. J Cell Biochem 2010; 110: 1324-1333.
13. Weitsman G, Ravid A, Liberman UA, Koren R. Vitamin D enhances caspase-dependent and independent TNF-induced breast cancer cell death: the role of reactive oxygen species. Int J Cancer 2003; 106: 178-186.
14. 3 and its analogues increase catalase at the mRNA, protein and activity level in a canine transitional carcinoma cell line. Vet Comp Oncol 2013; 12: 1-12.
15. 3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000; 164: 287-6295.
16. 3 up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 2002; 277: 26496-26500.
17. Nakai K, Fujii H, Kono K, et al. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats. Am J Hypertens 2014; 27: 586-595.
18. 2 oxidant injury through the Mek/Erk-Sirt1 axis activation. J Cardiovasc Transl Res 2013; 6: 221-231.
19. 3 and Ajuga iva extract on oxidative stress, toxicity and hypo-fertility in diabetic rat testes. J Physiol Biochem 2008; 63: 231-240.
20. 3: therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats. J Nutr Sci Vitaminol 2009; 55: 215-222.
21. Wright AF, Chakarova CF, Abd EI-Aziz MM, Bhattacharya SS. Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat Rev Genet 2010; 11: 273-284.
22. Daiger SP, Sullivan LS, Bowne SJ. Genes and mutations causing retinitis pigmentosa. Clin Genet 2011; 84: 132-142.
23. Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A. Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet 2014; 15: 5.1-5.21.
24. Punzo C, Xiong W, Cepko CL. Loss of daylight vision in retinal degeneration: are oxidative stress and metabolic dysregulation to blame? J Biol Chem 2012; 287: 1642-1648.
25. Vlachantoni D, Bramall AN, Murphy MP, et al. Evidence of severe mitochondrial oxidative stress and a protective effect of low oxygen in mouse models of inherited photoreceptor degeneration. Hum Mol Genet 2011; 20: 322-335.
26. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009; 28: 1-18.
27. Yoshida N, Ikeda Y, Notomi S, et al. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 2013; 120: 100-105.
28. al-Ubaidi MR, Font RL, Quiambao AB, et al. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J Cell Biol 1992; 119: 1681-1687.
29. Tan E, Ding XQ, Saadi A, Agarwal N, Naash MI, Al-Ubaidi MR. Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci 2004; 45: 764-768.
30. Mackey A, Sanvicens N, Groeger G, Doonan F, Wallace D, Cotter TG. Redox survival signaling in retina-derived 661W cells. Cell Death Differ 2008; 15: 1291-1303.
31. Aranda A, Sequedo L, Tolosa L, et al. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol In Vitro 2013; 27: 954-963.
32. Craig TA, Sommer S, Sussman CR, Grande JP, Kumar R. Expression and regulation of the vitamin D receptor in the zebrafish, Danio rerio. J Bone Miner Res 2008; 23: 1486-1496.
33. Alsalem JA, Patel D, Susarla R, et al. Characterization of vitamin D production by human ocular barrier cells. Invest Ophthalmol Vis Sci 2014; 55: 2140-2147.
34. Scandalios J. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 2005; 38: 995-1014.
35. Kopp A, Hebecker M, Svobodova E, Jozsi M. Factor H: a complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules 2012; 2: 46-75.
36. De la Cámara C, Salom D, Sequedo MD, et al. Altered antioxidant-oxidant status in the aqueous humor and peripheral blood of patients with retinitis pigmentosa. PLoS One 2013; 8: 1-8.
37. Musarella M, MacDonald IM. Current concepts in the treatment of retinitis pigmentosa. J Ophthalmol 2011; 10: 1-8.
38. Komeima K, Rogers BS, Lu L, Campochiaro PA. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci 2006; 130: 11300-11305.
39. Lu L, Oveson BC, Jo YJ, et al. Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage. Antioxid Redox Signal 2009; 11: 715-724.
40. Cheng Y, Takeuchi H, Sonobe Y, et al. Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes. J Neuroimmunol 2014; 15: 38-43.
41. Zhong W, Gu B, Gu Y, Groome LJ, Sun J, Wang Y. Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells. J Steroid Biochem Mol Biol 2014; 140: 56-62.
42. 3 Protects against macrophage-induced activation of NFκB and MAPK signaling and chemokine release in human adipocytes. PLoS One 2013; 8: 1-14.
43. Miodovnik M, Koren R, Ziv E, Ravid A. The inflammatory response of keratinocytes and its modulation by vitamin D: the role of MAPK signaling pathways. J Cell Physiol 2012; 227: 2175-2183.
44. Zhang H, Xie SL, Chen YX, et al. Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress. J Transl Med 2012; 10: 1-12.
45. 3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 2006; 29: 1883-1893.
46. 3. Oncogene 2009; 28: 3892-3902.
47. 2-mediated cell death and enhances electroretinography response in dim-reared albino rats. Mol Vis 2012; 18: 1325-1338.
48. Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkB activity by increasing IkBa levels. Nephrol Dial Transplant 2006; 21: 889-897.
49. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103-110.
50. Zhang HF, Xie SL, Chen YX, et al. Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress. J Transl Med 2012; 10: 120.
51. Liu X, Liu XF, Jian CX, Li CJ, He SZ. IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells. Inflammation 2012; 35: 776-784.
52. Tezel G, Yang X, Luo C, et al. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci 2010; 51: 5071-5082.
53. Wu Z, Lauer TW, Sick A, Hackett SF, Campochiaro PA. Oxidative stress modulates complement factor H expression in retinal pigmented epithelial cells by acetylation of FOXO3. J Biol Chem 2007; 282: 22414-22425.
54. Luo C, Chen M, Xu H. Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid. Mol Vis 2011; 17: 1588-1597.
55. 3 regulates in vivo production of the third component of complement (C3) in bone. Endocrinology 1992; 131: 2468-2475.
56. 3 and cAMP synergistically induce complement 5a receptor messenger RNA. Am J Med Sci 1996; 311: 73-79.
57. An B, Tavera-Mendoza LE, Dimitrov V, et al. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol Cell Biol 2010; 30: 4890-4900.
58. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol 2007; 125: 661-669.
59. Millen AE, Voland R, Sondel SA, et al. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol 2011; 129: 481-489.
60. Morrison MA, Silveira AC, Huynh N, et al. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics 2011; 5: 538-568.
61. Graffe A, Milea D, Annweiler C, et al. Association between hypovitaminosis D and late stages of age-related macular degeneration: a case-control study. J Am Geriatr Soc 2012; 60: 1367-1369.